Search results summary
From Health Canada
Search criteria
- Status: Select all
- AIG: 0152691001
Search results
| Status | DIN | Company | Product | Class | PM See footnote1 | Schedule | # See footnote2 | A.I. name See footnote3 | Strength |
|---|---|---|---|---|---|---|---|---|---|
| Approved | 02565943 | SHANGHAI HENLIUS BIOTECH, INC. | BILDYOS | Human | Yes | SCHEDULE D | 1 | DENOSUMAB | 60 MG / ML |
| Approved | 02565943 | SHANGHAI HENLIUS BIOTECH, INC. | BILDYOS | Human | Yes | PRESCRIPTION | 1 | DENOSUMAB | 60 MG / ML |
| Marketed | 02565951 | SHANGHAI HENLIUS BIOTECH, INC. | BILDYOS | Human | Yes | PRESCRIPTION | 1 | DENOSUMAB | 60 MG / ML |
| Marketed | 02565951 | SHANGHAI HENLIUS BIOTECH, INC. | BILDYOS | Human | Yes | SCHEDULE D | 1 | DENOSUMAB | 60 MG / ML |
| Approved | 02567253 | BIOSIMILAR COLLABORATIONS IRELAND LIMITED | BOSAYA | Human | Yes | SCHEDULE D | 1 | DENOSUMAB | 60 MG / ML |
| Approved | 02567253 | BIOSIMILAR COLLABORATIONS IRELAND LIMITED | BOSAYA | Human | Yes | PRESCRIPTION | 1 | DENOSUMAB | 60 MG / ML |
| Approved | 02567660 | FRESENIUS KABI CANADA LTD | CONEXXENCE | Human | Yes | PRESCRIPTION | 1 | DENOSUMAB | 60 MG / 1 ML |
| Approved | 02567660 | FRESENIUS KABI CANADA LTD | CONEXXENCE | Human | Yes | SCHEDULE D | 1 | DENOSUMAB | 60 MG / 1 ML |
| Approved | 02566265 | APOTEX INC | DENOZA | Human | Yes | SCHEDULE D | 1 | DENOSUMAB | 60 MG / ML |
| Approved | 02566265 | APOTEX INC | DENOZA | Human | Yes | PRESCRIPTION | 1 | DENOSUMAB | 60 MG / ML |
| Marketed | 02545411 | SANDOZ CANADA INCORPORATED | JUBBONTI | Human | Yes | SCHEDULE D | 1 | DENOSUMAB | 60 MG / ML |
| Marketed | 02545411 | SANDOZ CANADA INCORPORATED | JUBBONTI | Human | Yes | PRESCRIPTION | 1 | DENOSUMAB | 60 MG / ML |
| Approved | 02567482 | SAMSUNG BIOEPIS CO., LTD | OBODENCE | Human | Yes | PRESCRIPTION | 1 | DENOSUMAB | 60 MG / 1 ML |
| Approved | 02567482 | SAMSUNG BIOEPIS CO., LTD | OBODENCE | Human | Yes | SCHEDULE D | 1 | DENOSUMAB | 60 MG / 1 ML |
| Approved | 02569787 | JAMP PHARMA CORPORATION | ODENSIFY | Human | Yes | PRESCRIPTION | 1 | DENOSUMAB | 60 MG / ML |
| Approved | 02569787 | JAMP PHARMA CORPORATION | ODENSIFY | Human | Yes | SCHEDULE D | 1 | DENOSUMAB | 60 MG / ML |
| Marketed | 02343541 | AMGEN CANADA INC | PROLIA | Human | Yes | PRESCRIPTION | 1 | DENOSUMAB | 60 MG / ML |
| Marketed | 02343541 | AMGEN CANADA INC | PROLIA | Human | Yes | SCHEDULE D | 1 | DENOSUMAB | 60 MG / ML |
| Cancelled Pre Market | 02343568 | AMGEN CANADA INC | PROLIA | Human | Yes | SCHEDULE D | 1 | DENOSUMAB | 60 MG / ML |
| Cancelled Pre Market | 02343568 | AMGEN CANADA INC | PROLIA | Human | Yes | PRESCRIPTION | 1 | DENOSUMAB | 60 MG / ML |
| Marketed | 02560917 | CELLTRION INC. | STOBOCLO | Human | Yes | SCHEDULE D | 1 | DENOSUMAB | 60 MG / ML |
| Marketed | 02560917 | CELLTRION INC. | STOBOCLO | Human | Yes | PRESCRIPTION | 1 | DENOSUMAB | 60 MG / ML |
Application information
Related information
Contact us
Version 4.1.0